Literature DB >> 7438541

Serological investigations on Indian kala-azar.

A C Ghose, J P Haldar, S C Pal, B P Mishra, K K Mishra.   

Abstract

Detailed serological investigations were carried out in forty-nine active kala-azar (KA) cases in North Bihar, India. Various classes of immunoglobulin (IgG, IgA, and IgM) and third component of complement (C3) levels were determined in these sera and results were compared with those obtained in normal controls. Antibody titres were determined by the indirect haemagglutination (IHA) method using soluble Leishmania antigen. Immunoglobulin G and M class-specific antibody titres were also determined separately by the enzyme-linked immunosorbent assay (ELISA) method. Polyclonal hypergammaglobulinaemia with marked increase in serum IgG (and to a lesser extent in IgM) level was a rather common feature in the majority of these sera. Much of this immunoglobulin increase, however, appeared to be non-specific in nature and no absolute correlation could be noted between serum IgG or IgM levels and corresponding IgG or IgM antibody titres. Significant decrease in serum C3 level was observed in KA and this decrease was found to be independent of immunoglobulin levels or specific antibody titres. A fairly good correlation between aldehyde test and serum IgG level was evident from this study. Aldehyde-positive KA sera usually gave higher antibody titres than aldehyde-negative ones. Anti-leishmanial antibodies belonged mostly to IgG class although some IgM antibodies were also demonstrable. The latter class of antibodies probably appeared early in KA infection although their serological specificity was poorer to IgG antibodies. Out of forty-nine KA sera examined in this study thirty-six (73.5%) gave positive IHA titres while forty-six (93.9%) were positive by IgG-ELISA which appeared to be a highly specific and sensitive serodiagnostic method particularly for the early detection of KA cases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438541      PMCID: PMC1536996     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The anaemia of kala-azar.

Authors:  A W Woodruff; E Topley; R Knight; C G Downie
Journal:  Br J Haematol       Date:  1972-03       Impact factor: 6.998

3.  Immunoelectrophoretic analysis of serum proteins of patients affected by kala-azar.

Authors:  A Priolisi; L Giuffrè
Journal:  Pathol Microbiol (Basel)       Date:  1967

4.  Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

5.  A research standard for human serum immunoglobulins IgG, IgA and IgM.

Authors:  D S Rowe; S G Anderson; B Grab
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Haematological aspects of Indian kalaazar.

Authors:  J B Chatterjea; P C Sen Gupta
Journal:  J Indian Med Assoc       Date:  1970-06-16

8.  Enzyme immunoassays for parasitic diseases.

Authors:  A Bartlett; D E Bidwell
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

Review 9.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

10.  The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis.

Authors:  M Hommel; W Peters; J Ranque; M Quilici; G Lanotte
Journal:  Ann Trop Med Parasitol       Date:  1978-06
View more
  27 in total

1.  Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.

Authors:  R Kumar; K Pai; K Pathak; S Sundar
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Elevation of serum B-cell activating factor levels during visceral leishmaniasis.

Authors:  Yasuyuki Goto; Satoko Omachi; Chizu Sanjoba; Yoshitsugu Matsumoto
Journal:  Am J Trop Med Hyg       Date:  2014-08-25       Impact factor: 2.345

3.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

4.  Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis.

Authors:  Rosângela Barbosa-De-Deus; Marcos Luíz Dos Mares-Guia; Adriane Zacarias Nunes; Kátia Morais Costa; Roberto Gonçalves Junqueira; Wilson Mayrink; Odair Genaro; Carlos Alberto Pereira Tavares
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  ELISA with recombinant rKRP42 antigen using urine samples: a tool for predicting clinical visceral leishmaniasis cases and its outbreak.

Authors:  Mohammad Zahidul Islam; Makoto Itoh; Md Anwar Ul Islam; A R M Saifuddin Ekram; Md Ajijur Rahman; Hidekazu Takagi; Atsuhide Takesue; Yoshihisa Hashiguchi; Eisaku Kimura
Journal:  Am J Trop Med Hyg       Date:  2012-08-06       Impact factor: 2.345

6.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

7.  Persistence of elevated levels of galactosyl-alpha(1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis.

Authors:  J L Avila; M Rojas; L García
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

9.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.

Authors:  E M el Amin; E P Wright; A Vlug
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.